Clinical experience with bosentan and sitaxentan in connective tissue disease-associated pulmonary arterial hypertension

Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)

(2009) et al.   EUROPEAN HEART JOURNAL

Diagnosis and Assessment of Pulmonary Arterial Hypertension

(2009) David B. Badesch et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Updated Clinical Classification of Pulmonary Hypertension

(2009) Gérald Simonneau et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Endothelin Receptor Antagonists for Pulmonary Arterial Hypertension

(2008) Laura C Price et al.   American Journal of Cardiovascular Drugs

Connective Tissue Disease–associated Pulmonary Arterial Hypertension in the Modern Treatment Era

(2008) Robin Condliffe et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Sitaxsentan for the Treatment of Pulmonary Arterial Hypertension

(2008) Raymond L. Benza et al.   CHEST

Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?

(2008) Christian F. Opitz et al.   EUROPEAN HEART JOURNAL